Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses

Laszlo Hunyadi, Emily Sundman, Phili Kass, D Williams, Monica Aleman

Research output: Contribution to journalArticlepeer-review


<b>Background: </b>Immune-mediated myositis (IMM) is a cause of rhabdomyolysis, stiffness, and muscle atrophy predominantly affecting Quarter horses. Limited information is available with regard to outcome, prognostic indicators, and associations with concurrent diseases. <br><b>Hypothesis/objectives: </b>To report outcomes and associations between outcome and clinical and laboratory parameters, and presence of concurrent illness. <br> <b>Animals: </b>Sixty-eight horses; 52 Quarter horses and related breeds and 16 other breeds. <br> <b>Methods: </b>Retrospective cohort study (1991-2014). Medical records of horses with histological diagnosis of IMM were reviewed. Data recovery included signalment, laboratory variables, therapy, and outcome. Logistic regression was used to quantify the association between potential prognostic factors and survival to discharge. <br>
Original languageEnglish
Pages (from-to)170-175
JournalJournal of Veterinary Internal Medicine
StatePublished - Jan 2017


Dive into the research topics of 'Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses'. Together they form a unique fingerprint.

Cite this